Marshall Wace, LLP Anixa Biosciences Inc Transaction History

Marshall Wace, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$3.08 - $5.02 $48,346 - $78,798	15,697 Added 147.04%	26,372 $82,000
Q4 2023 Feb 14, 2024	BUY	$2.85 - $4.19 $30,423 - $44,728	10,675 New	10,675 $41,000
Q2 2022 Aug 15, 2022	SELL	$2.55 - $4.1 $73,753 - $118,584	-28,923 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.5 - $3.42 $32,625 - $44,631	-13,050 Reduced 31.09%	28,923 $80,000
Q3 2021 Nov 15, 2021	BUY	$3.57 - $5.6 $149,843 - $235,048	41,973 New	41,973 $200,000

5.5M

Ticker ANIX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,661,700
Market Cap $97.8M
Description
Anixa Biosciences, Inc., a biotechnology company, develops therapies and vaccines focusing on critical unmet needs in oncology and infectious diseases. The company's therapeutics programs include the development of a chimeric endocrine receptor T-cell technology, a novel form of chimeric antigen receptor T-cell (CAR-T) technology focusing on the...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.